Evidence map›Paper›PMID 41338984›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Sporadic Late-onset Nemaline Myopathy Associated with Multiple Myeloma.

Yoshihiro Furukawa, Keiichi Hokkoku, Yuichi Furukawa, Yuki Hagiwara, Akatsuki Kubota, Jun Shimizu, Ryosuke Shirasaki, Shunsuke Kobayashi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yoshihiro FurukawaDepartment of Neurology, Teikyo University School of Medicine, Japan.
Keiichi HokkokuDepartment of Neurology, Teikyo University School of Medicine, Japan.
Yuichi FurukawaDepartment of Neurology, Teikyo University School of Medicine, Japan.
Yuki HagiwaraDepartment of Neurology, Teikyo University School of Medicine, Japan.
Akatsuki KubotaDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Jun ShimizuDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Ryosuke ShirasakiDepartment of Hematology/Oncology, Teikyo University School of Medicine, Japan.
Shunsuke KobayashiDepartment of Neurology, Teikyo University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic late-onset nemaline myopathy (SLONM) is a rare, acquired myopathy that is frequently associated with monoclonal gammopathy, most commonly monoclonal gammopathy of undetermined significance (MGUS). However, its association with overt multiple myeloma (MM) has been rarely reported. We present a case of SLONM associated with MM in which chemotherapy targeting the underlying MM led to mild-to-moderate improvement in muscle symptoms. This case underscores the potential pathogenic role of MM in SLONM and highlights the importance of treating underlying hematologic malignancies.

Indexed as

Multiple MyelomaMyopathies, NemalineFemaleHumansMiddle Ageddaratumumabintravenous immunoglobulinmonoclonal gammopathymultiple myelomamuscle biopsySLONM

Identifiers

PMID41338984
PMCPMC13423772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.